These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17064666)

  • 41. Proteomics analysis of human umbilical vein endothelial cells treated with resveratrol.
    Shao B; Tang M; Li Z; Zhou R; Deng Y; Nie C; Yuan Z; Zhou L; Tang M; Tong A; Wei Y
    Amino Acids; 2012 Oct; 43(4):1671-8. PubMed ID: 22349766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resveratrol protects adult cardiomyocytes against oxidative stress mediated cell injury.
    Movahed A; Yu L; Thandapilly SJ; Louis XL; Netticadan T
    Arch Biochem Biophys; 2012 Nov; 527(2):74-80. PubMed ID: 22633977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of firefly luciferase activity assays to monitor circadian molecular rhythms in vivo and in vitro.
    Yu W; Hardin PE
    Methods Mol Biol; 2007; 362():465-80. PubMed ID: 17417035
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonisotopic assays for reporter gene activity.
    Brasier AR; Fortin JJ
    Curr Protoc Pharmacol; 2001 May; Chapter 6():Unit 6.5. PubMed ID: 21965076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A specific mechanism for nonspecific activation in reporter-gene assays.
    Auld DS; Thorne N; Nguyen DT; Inglese J
    ACS Chem Biol; 2008 Aug; 3(8):463-70. PubMed ID: 18590332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The dual luciferase reporter system and RT-qPCR strategies for screening of MicroRNA-21 small-molecule inhibitors.
    Hei YY; Guo YX; Jiang CS; Wang S; Lu SM; Zhang SQ
    Biotechnol Appl Biochem; 2019 Sep; 66(5):755-762. PubMed ID: 31021480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death.
    Fox JT; Sakamuru S; Huang R; Teneva N; Simmons SO; Xia M; Tice RR; Austin CP; Myung K
    Proc Natl Acad Sci U S A; 2012 Apr; 109(14):5423-8. PubMed ID: 22431602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A potentially general method for the in vivo selection of inhibitory peptides targeted at a specific protein using yeast.
    Daniel JH
    Curr Genet; 2008 Jun; 53(6):373-9. PubMed ID: 18478232
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Imaging cytokine targeting to the tumor/bone microenvironment in vivo.
    Ellis J; Falzon M; Emrick T; Figueiredo ML
    Hum Gene Ther Clin Dev; 2014 Dec; 25(4):200-1. PubMed ID: 25495534
    [No Abstract]   [Full Text] [Related]  

  • 50. Cardiovascular effects of resveratrol.
    Bukarica LG; Protić D; Kanjuh V; Heinle H; Novakoviĉ R; Sćepanović R
    Vojnosanit Pregl; 2013 Dec; 70(12):1145-50. PubMed ID: 24450260
    [No Abstract]   [Full Text] [Related]  

  • 51. Resveratrol and vitamin D: significant potential interpretative problems arising from their mutual processes, interactions and effects.
    Hayes DP
    Med Hypotheses; 2011 Nov; 77(5):765-72. PubMed ID: 21840648
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of human basophil activation by resveratrol.
    Tanaka Y; Yamaguchi M; Suzukawa M; Arai H; Nagase H; Ohta K
    Allergol Int; 2015 Sep; 64 Suppl():S80-2. PubMed ID: 26344086
    [No Abstract]   [Full Text] [Related]  

  • 53. Nonsense suppression activity of PTC124 (ataluren).
    Peltz SW; Welch EM; Jacobson A; Trotta CR; Naryshkin N; Sweeney HL; Bedwell DM
    Proc Natl Acad Sci U S A; 2009 Jun; 106(25):E64; author reply E65. PubMed ID: 19506240
    [No Abstract]   [Full Text] [Related]  

  • 54. A special BioFactors issue dedicated to resveratrol.
    Pirola L
    Biofactors; 2010; 36(5):329-30. PubMed ID: 20872759
    [No Abstract]   [Full Text] [Related]  

  • 55. Firefly luciferase in chemical biology: a compendium of inhibitors, mechanistic evaluation of chemotypes, and suggested use as a reporter.
    Thorne N; Shen M; Lea WA; Simeonov A; Lovell S; Auld DS; Inglese J
    Chem Biol; 2012 Aug; 19(8):1060-72. PubMed ID: 22921073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Firefly luciferase inhibition.
    Leitão JM; Esteves da Silva JC
    J Photochem Photobiol B; 2010 Oct; 101(1):1-8. PubMed ID: 20655239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of Modulators of the
    Larigot L; Bui LC; de Bouvier M; Pierre O; Pinon G; Fiocca J; Ozeir M; Tourette C; Ottolenghi C; Imbeaud S; Pontoizeau C; Blaise BJ; Chevallier A; Tomkiewicz C; Legrand B; Elena-Herrmann B; Néri C; Brinkmann V; Nioche P; Barouki R; Ventura N; Dairou J; Coumoul X
    Antioxidants (Basel); 2022 May; 11(5):. PubMed ID: 35624894
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of 2-Benzylidene-tetralone Derivatives as Highly Potent and Reversible Firefly Luciferase Inhibitors.
    Li Y; Jin C; Xu H; Wu W; Wang Y; Wu J; Liu T; Wan G; Yue X; Bu X
    ACS Med Chem Lett; 2022 Feb; 13(2):304-311. PubMed ID: 35178187
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays.
    Curreli F; Ahmed S; Victor SMB; Drelich A; Panda SS; Altieri A; Kurkin AV; Tseng CK; Hillyer CD; Debnath AK
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062273
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.